Back to JNGHFView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
View Full LandscapeDrug Information
Target Indication
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
Clinical Trial
NCT07311694Last updated: 2/11/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Irinotecan liposome、5-Fluorouracil、LeucovorinPhase 3
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
ApatinibPhase 3
Carcinoma, Hepatocellular
X0002 SprayPhase 3
KNEE OSTEOARTHRITIS
JSKN003Phase 3
Advanced Solid Tumor
Propofol Medium and Long Chain Fat Emulsion InjectionPhase 3
Sedation in the ICU
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts